The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Prostaglandin Market Research Report 2024
Synopsis
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Human Prostaglandin market was valued at US$ 398 million in 2023 and is anticipated to reach US$ 663 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Prostaglandin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prostaglandin.
Report Scope
The Human Prostaglandin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Prostaglandin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Prostaglandin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Segment by Type
(+)-Cloprostenol issopropylester
Latanoprost
Bimatoprost
Alprostadil
Misoprostol
Dinoprostone
Carboprost
CarboprostMethylate
Others
Segment by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Prostaglandin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Prostaglandin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Human Prostaglandin market was valued at US$ 398 million in 2023 and is anticipated to reach US$ 663 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Prostaglandin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prostaglandin.
Report Scope
The Human Prostaglandin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Prostaglandin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Prostaglandin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Segment by Type
(+)-Cloprostenol issopropylester
Latanoprost
Bimatoprost
Alprostadil
Misoprostol
Dinoprostone
Carboprost
CarboprostMethylate
Others
Segment by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Prostaglandin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Prostaglandin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Prostaglandin Market Overview
1.1 Product Overview and Scope of Human Prostaglandin
1.2 Human Prostaglandin Segment by Type
1.2.1 Global Human Prostaglandin Market Value Comparison by Type (2024-2030)
1.2.2 (+)-Cloprostenol issopropylester
1.2.3 Latanoprost
1.2.4 Bimatoprost
1.2.5 Alprostadil
1.2.6 Misoprostol
1.2.7 Dinoprostone
1.2.8 Carboprost
1.2.9 CarboprostMethylate
1.2.10 Others
1.3 Human Prostaglandin Segment by Application
1.3.1 Global Human Prostaglandin Market Value by Application: (2024-2030)
1.3.2 Cardiovascular
1.3.3 Gynecological and Obstetrical
1.3.4 Ophthalmologic
1.3.5 Others
1.4 Global Human Prostaglandin Market Size Estimates and Forecasts
1.4.1 Global Human Prostaglandin Revenue 2019-2030
1.4.2 Global Human Prostaglandin Sales 2019-2030
1.4.3 Global Human Prostaglandin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Prostaglandin Market Competition by Manufacturers
2.1 Global Human Prostaglandin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Prostaglandin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Prostaglandin Average Price by Manufacturers (2019-2024)
2.4 Global Human Prostaglandin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Prostaglandin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Prostaglandin, Product Type & Application
2.7 Human Prostaglandin Market Competitive Situation and Trends
2.7.1 Human Prostaglandin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Prostaglandin Players Market Share by Revenue
2.7.3 Global Human Prostaglandin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Prostaglandin Retrospective Market Scenario by Region
3.1 Global Human Prostaglandin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Prostaglandin Global Human Prostaglandin Sales by Region: 2019-2030
3.2.1 Global Human Prostaglandin Sales by Region: 2019-2024
3.2.2 Global Human Prostaglandin Sales by Region: 2025-2030
3.3 Global Human Prostaglandin Global Human Prostaglandin Revenue by Region: 2019-2030
3.3.1 Global Human Prostaglandin Revenue by Region: 2019-2024
3.3.2 Global Human Prostaglandin Revenue by Region: 2025-2030
3.4 North America Human Prostaglandin Market Facts & Figures by Country
3.4.1 North America Human Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Prostaglandin Sales by Country (2019-2030)
3.4.3 North America Human Prostaglandin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Prostaglandin Market Facts & Figures by Country
3.5.1 Europe Human Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Prostaglandin Sales by Country (2019-2030)
3.5.3 Europe Human Prostaglandin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Human Prostaglandin Market Facts & Figures by Country
3.6.1 Asia Pacific Human Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Prostaglandin Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Prostaglandin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Human Prostaglandin Market Facts & Figures by Country
3.7.1 Latin America Human Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Prostaglandin Sales by Country (2019-2030)
3.7.3 Latin America Human Prostaglandin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Prostaglandin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Prostaglandin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Prostaglandin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Prostaglandin Sales by Type (2019-2030)
4.1.1 Global Human Prostaglandin Sales by Type (2019-2024)
4.1.2 Global Human Prostaglandin Sales by Type (2025-2030)
4.1.3 Global Human Prostaglandin Sales Market Share by Type (2019-2030)
4.2 Global Human Prostaglandin Revenue by Type (2019-2030)
4.2.1 Global Human Prostaglandin Revenue by Type (2019-2024)
4.2.2 Global Human Prostaglandin Revenue by Type (2025-2030)
4.2.3 Global Human Prostaglandin Revenue Market Share by Type (2019-2030)
4.3 Global Human Prostaglandin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Prostaglandin Sales by Application (2019-2030)
5.1.1 Global Human Prostaglandin Sales by Application (2019-2024)
5.1.2 Global Human Prostaglandin Sales by Application (2025-2030)
5.1.3 Global Human Prostaglandin Sales Market Share by Application (2019-2030)
5.2 Global Human Prostaglandin Revenue by Application (2019-2030)
5.2.1 Global Human Prostaglandin Revenue by Application (2019-2024)
5.2.2 Global Human Prostaglandin Revenue by Application (2025-2030)
5.2.3 Global Human Prostaglandin Revenue Market Share by Application (2019-2030)
5.3 Global Human Prostaglandin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi CEPiA
6.1.1 Sanofi CEPiA Corporation Information
6.1.2 Sanofi CEPiA Description and Business Overview
6.1.3 Sanofi CEPiA Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi CEPiA Human Prostaglandin Product Portfolio
6.1.5 Sanofi CEPiA Recent Developments/Updates
6.2 Kyowa Hakko Pharma
6.2.1 Kyowa Hakko Pharma Corporation Information
6.2.2 Kyowa Hakko Pharma Description and Business Overview
6.2.3 Kyowa Hakko Pharma Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Kyowa Hakko Pharma Human Prostaglandin Product Portfolio
6.2.5 Kyowa Hakko Pharma Recent Developments/Updates
6.3 Cayman Chemical
6.3.1 Cayman Chemical Corporation Information
6.3.2 Cayman Chemical Description and Business Overview
6.3.3 Cayman Chemical Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cayman Chemical Human Prostaglandin Product Portfolio
6.3.5 Cayman Chemical Recent Developments/Updates
6.4 Yonsung Fine Chemicals
6.4.1 Yonsung Fine Chemicals Corporation Information
6.4.2 Yonsung Fine Chemicals Description and Business Overview
6.4.3 Yonsung Fine Chemicals Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yonsung Fine Chemicals Human Prostaglandin Product Portfolio
6.4.5 Yonsung Fine Chemicals Recent Developments/Updates
6.5 Johnson Matthey
6.5.1 Johnson Matthey Corporation Information
6.5.2 Johnson Matthey Description and Business Overview
6.5.3 Johnson Matthey Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson Matthey Human Prostaglandin Product Portfolio
6.5.5 Johnson Matthey Recent Developments/Updates
6.6 Chirogate
6.6.1 Chirogate Corporation Information
6.6.2 Chirogate Description and Business Overview
6.6.3 Chirogate Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chirogate Human Prostaglandin Product Portfolio
6.6.5 Chirogate Recent Developments/Updates
6.7 Everlight Chemical
6.6.1 Everlight Chemical Corporation Information
6.6.2 Everlight Chemical Description and Business Overview
6.6.3 Everlight Chemical Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Everlight Chemical Human Prostaglandin Product Portfolio
6.7.5 Everlight Chemical Recent Developments/Updates
6.8 ANVI Pharma
6.8.1 ANVI Pharma Corporation Information
6.8.2 ANVI Pharma Description and Business Overview
6.8.3 ANVI Pharma Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ANVI Pharma Human Prostaglandin Product Portfolio
6.8.5 ANVI Pharma Recent Developments/Updates
6.9 AUSUN Pharmaceutical
6.9.1 AUSUN Pharmaceutical Corporation Information
6.9.2 AUSUN Pharmaceutical Description and Business Overview
6.9.3 AUSUN Pharmaceutical Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AUSUN Pharmaceutical Human Prostaglandin Product Portfolio
6.9.5 AUSUN Pharmaceutical Recent Developments/Updates
6.10 Aspen Biopharma Labs
6.10.1 Aspen Biopharma Labs Corporation Information
6.10.2 Aspen Biopharma Labs Description and Business Overview
6.10.3 Aspen Biopharma Labs Human Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aspen Biopharma Labs Human Prostaglandin Product Portfolio
6.10.5 Aspen Biopharma Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Prostaglandin Industry Chain Analysis
7.2 Human Prostaglandin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Prostaglandin Production Mode & Process
7.4 Human Prostaglandin Sales and Marketing
7.4.1 Human Prostaglandin Sales Channels
7.4.2 Human Prostaglandin Distributors
7.5 Human Prostaglandin Customers
8 Human Prostaglandin Market Dynamics
8.1 Human Prostaglandin Industry Trends
8.2 Human Prostaglandin Market Drivers
8.3 Human Prostaglandin Market Challenges
8.4 Human Prostaglandin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
